[NCEZID] Emerging Infections Program

OMB Control No: 0920-0978	ICR Reference No: 202505-0920-009
Status: Received in OIRA	Previous ICR Reference No: 202504-0920-028
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-25-0122
Title: [NCEZID] Emerging Infections Program
Type of Information Collection: No material or nonsubstantive change to a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular	Date Submitted to OIRA: 06/03/2025

	Requested	Previously Approved
Expiration Date	09/30/2027	09/30/2027
Responses	88,158	88,158
Time Burden (Hours)	40,013	40,013
Cost Burden (Dollars)	0	0

---

Abstract: The Emerging Infections Programs (EIP) is to 1) detect and monitor emerging pathogens, the diseases they cause, and the factors influencing their emergence, and respond to problems as they are identified, 2) integrate laboratory science and epidemiology to optimize public health practice, 3) strengthen infrastructure to support surveillance and research and to implement prevention and control programs, and to 4) ensure implementation of prevention strategies and communication of public health information about emerging diseases. Surveillance efforts of the core EIP activities generate reliable estimates of the incidence of certain infections and provide the foundation for a variety of epidemiologic studies. This Non-Substantive Change Request is submitted to make minor modifications to approved instruments including revised formatting, rewording, new answer options, and the addition/subtraction of a limited number of questions. There is no anticipated change to the approved burden hours.

---

Authorizing Statute(s): US Code: 42 USC 301 Name of Law: Public Health Service Act

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	89 FR 14501	02/27/2024
30-day Notice:	Federal Register Citation:	Citation Date:
	89 FR 58736	07/19/2024
Did the Agency receive public comments on this ICR? No

---

Number of Information Collection (IC) in this ICR: 32

IC Title Form No. Form Name (MuGSI) Healthcare-Associated Infections Community Interface (HAIC) Case Report HAIC 400.1, HAIC 400.1, HAIC 400.1 2024 Multi-site Gram-Negative Surveillance Initiative (MuGSI) Healthcare-Associated Infections Community Interface (HAIC) Case Report_rev 2025 ,   2025 Multi-site Gram-Negative Surveillance Initiative (MuGSI) Healthcare-Associated Infections Community Interface (HAIC) Case Report _rev 2025 ,   HAIC.400.1 Multi-Site Gram-Negative Surveillance Initiative (MuGSI) Case Report Form - 2026 2019 ABCs H. Influenzae Neonatal Sepsis Expanded Surveillance Form ABC.100.3 2019 ABC H. Influenzae Neonatal Sepsis Expanded Surveillance Form 2024 Active Bacterial Core Surveillance (ABCs) Case Report ABC.100.1, ABC 100.1 2024 Active Bacterial Core Surveillance (ABCs) Case Report ,   2025 Active Bacterial Core Surveillance (ABCs) Case Report ABCs Invasive Pneumococcal Disease in Children and Adults ABC.100.2, ABC 100.2 ACTIVE BACTERIAL CORE SURVEILLANCE (ABCs) INVASIVE PNEUMOCOCCAL DISEASE IN CHILDREN (aged ≥2 months to <5 years) AND ADULTS (aged ≥65 years) ,   2025 ACTIVE BACTERIAL CORE SURVEILLANCE (ABCs) INVASIVE PNEUMOCOCCAL DISEASE IN CHILDREN (aged ≥2 months to <5 years) AND ADULTS (aged ≥65 years) ABCs Severe GAS Infection: Supplemental Form ABC.100.4 ABCs Severe GAS Infection: Supplemental Form Active Bacterial Core Surveillance (ABCs) Neonatal Infection Expanded Tracking Form ABC.100.5, ABC 100.5 ACTIVE BACTERIAL CORE SURVEILLANCE (ABCs) NEONATAL INFECTION EXPANDED TRACKING FORM ,   2025 ACTIVE BACTERIAL CORE SURVEILLANCE (ABCs) NEONATAL INFECTION EXPANDED TRACKING FORM Annual Survey of Laboratory Testing Practices for C. difficile Infection HAIC.400.8, HAIC 400.8, HAIC 400.8 Annual Survey of Laboratory Testing Practices for C. difficile Infection ,   Annual Survey of Laboratory Testing Practices for C. difficile Infection ,   HAIC.400.8 Annual Survey of Laboratory Testing Practices for C. difficile Infections - 2026 CANDIDEMIA 2024 CASE REPORT FORM HAIC 400.11, HAIC 400.11 CANDIDEMIA 2024 CASE REPORT FORM_rev 2025 ,   CANDIDEMIA 2025 CASE REPORT FORM_rev 2025 CDC's Healthcare-Associated Infections Community Interface (HAIC) Staphylococcus aureus 2024 Laboratory Survey HAIC.400.5 CDC’s Healthcare-Associated Infections Community Interface (HAIC) Staphylococcus aureus 2024 Laboratory Survey CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) SURVEILLANCE EMERGING INFECTIONS PROGRAM CASE REPORT HAIC 400.7, HAIC 400.7, HAIC 400.7 2024 CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) SURVEILLANCE EMERGING INFECTIONS PROGRAM CASE REPORT_rev 2025 ,   2025 CLOSTRIDIOIDES DIFFICILE INFECTION (CDI) SURVEILLANCE EMERGING INFECTIONS PROGRAM CASE REPORT_ rev 2025 ,   HAIC.400.7 CDI Case Report and Treatment Form - 2026 Community-Associated CP-CRE Interview HAIC.400.2 Community-Associated CP-CRE Interview Data Elements Transferred to CDC for the HAIC Death Ascertainment Project HAIC.400.13 Data Elements Transferred to CDC for the HAIC Death Ascertainment Project Emerging Infections Program C. difficile Surveillance Nursing Home Telephone Survey HAIC.400.10 Emerging Infections Program C. difficile Surveillance Nursing Home Telephone Survey FLUSURV-NET: CONSENT FORM FOR PATIENT/PROXY INTERVIEW (English/Spanish) FSN.300.2 FLUSURV-NET: CONSENT FORM FOR PATIENT/PROXY INTERVIEW FLUSURV-NET: PROVIDER PEDIATRIC VACCINATION HISTORY REQUEST LETTER/FORM FSN.300.3 FLUSURV-NET: PROVIDER PEDIATRIC VACCINATION HISTORY REQUEST LETTER/FORM FluSurv-NET Laboratory Survey 2023–2024 Season FSN.300.4 FluSurv-NET Laboratory Survey 2023–2024 Season FluSurv-Net Influenza Hospitalization Surveillance Network Case Report Form FSN.300.1, FSN 300.1 Influenza Hospitalizatin Surveillance Network (FluSurv-NET) Case Report Form ,   2024-25 Influenza Hospitalization Surveillance Network (FluSurv-NET) Case Report Form FoodNET Lab Survey Variable List 2024 FN.200.10 FoodNET Lab Survey Variable List, 2024 FoodNet Hemolytic Uremic Syndrome (HUS) ABC 200.9 FoodNet CDC's FoodNet Hemolytic Uremic Syndrome (HUS) Surveillance Case Report Form_rev 2025 FoodNet Variable List, 2024_ (CYCLOSPORA) FN200.2, FN.200.2, FN 200.2 FoodNet Variable List, 2024_ (CYCLOSPORA) ,   FoodNet Variable List, (Site-transmitted variables) - 2025 ,   FN200.1-200.8_FoodNet Variable List_2026 FoodNet Variable List, 2024_ (LISTERIA MONOCTOGENES) FN200.3, FN.200.3, FN 200.3 FoodNet Variable List, 2024_ (LISTERIA MONOCYTOGENES) ,   FoodNet Variable List, (Site-transmitted variables) - 2025 ,   FN200.1-200.8_FoodNet Variable List_2026 FoodNet Variable List, 2024_ (SALMONELLA) FN200.4, FN.200.4, FN 200.4 FoodNet Variable List, 2024_ (SALMONELLA) ,   FoodNet Variable List, (Site-transmitted variables) - 2025 ,   FN200.1-200.8_FoodNet Variable List_2026 FoodNet Variable List, 2024_ (SHIGA TOXIN PRODUCING E.COLI) FN200.5, FN.200.5, FN 200.5 FoodNet Variable List, 2024_ (SHIGA TOXIN PRODUCING E.COLI) ,   FoodNet Variable List, (Site-transmitted variables) - 2025 ,   FN200.1-200.8_FoodNet Variable List_2026 FoodNet Variable List, 2024_ (SHIGELLA) FN200.6, FN.200.6, FN 200.6 FoodNet Variable List, 2024_ (SHIGELLA) ,   FoodNet Variable List, (Site-transmitted variables) - 2025 ,   FN200.1-200.8_FoodNet Variable List_2026 FoodNet Variable List, 2024_ (VIBRIO) FN200.7, FN.200.7, FN 200.7 FoodNet Variable List, 2024_ (VIBRIO) ,   FoodNet Variable List, (Site-transmitted variables) - 2025 ,   FN200.1-200.8_FoodNet Variable List_2026 FoodNet Variable List, 2024_ (YERSINIA) FN200.8, FN.200.8, FN 200.8 FoodNet Variable List, 2024_ (YERSINIA) ,   FoodNet Variable List, (Site-transmitted variables) - 2025 ,   FN200.1-200.8_FoodNet Variable List_2026 FoodNet Variable List, 2024_(CAMPYLOBACTER) FN200.1, FN.200.1, FN 200.1 FoodNet Variable List, 2024_ (CAMPYLOBACTER) ,   FoodNet Variable List, (Site-transmitted variables) - 2025 ,   FN200.1-200.8_FoodNet Variable List_2026 HAIC Invasive Staphylococcus aureus Supplemental Surveillance Officer Survey HAIC.400.6, HAIC 400.6, HAIC 400.6 2023 HAIC Invasive Staphylococcus aureus Supplemental Surveillance Officer Survey ,   2024 HAIC Invasive Staphylococcus aureus Supplemental Surveillance Officer Survey ,   HAIC.400.6 HAIC Invasive Staphylococcus aureus Supplemental Surveillance Officer Survey - 2026 HAIC Multi-site Gram-negative Surveillance Initiative (MuGSI) Supplemental Surveillance Officer Survey HAIC.400.3, HAIC 400.3 2024 HAIC Multi-site Gram-negative Surveillance Initiative (MuGSI) Supplemental Surveillance Officer Survey ,   HAIC.400.3–HAIC MuGSI Supplemental Surveillance Officer Survey - 2026 HAIC-Surveillance Officer's Survey HAIC.400.9, HAIC 400.9, HAIC 400.9 HAIC Surveillance Officer’s Survey ,   HAIC Surveillance Officer’s Survey ,   HAIC.400.9 CDI Annual Surveillance Officers Survey - 2026 HAIC_LABORATORY TESTING PRACTICES FOR CANDIDEMIA QUESTIONNAIRE HAIC.400.12, HAIC 400.12 2024 LABORATORY TESTING PRACTICES FOR CANDIDEMIA QUESTIONNAIRE ,   2025 LABORATORY TESTING PRACTICES FOR CANDIDEMIA QUESTIONNAIRE Invasive Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report HAIC 400.4, HAIC 400.4, HAIC 400.4, HAIC 400.4, HAIC 400.4, HAIC 400.4, HAIC 400.4 2024 Invasive Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report_rev 2025 ,   2025 Invasive Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report_rev 2025 ,   2022 Invasive Methicillin-Resistant Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report _rev 2025 ,   2023 Invasive Methicillin-Resistant Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report _rev 2025 ,   2022 Invasive Methicillin-Sensitive Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report _rev 2025 ,   2023 Invasive Methicillin-Sensitive Staphylococcus aureus Healthcare-Associated Infections Community Interface (HAIC) Case Report _rev 2025 ,   HAIC.400.4 Invasive Staphylococcus aureus HAIC Case Report - 2026

---

ICR Summary of Burden

	Total Request	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	88,158	88,158	0	0	0	0
Annual Time Burden (Hours)	40,013	40,013	0	0	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: No

Burden Increase Due to:

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement:

---

Annual Cost to Federal Government: $41,699,051

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     Yes

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

Agency Contact: Jeffrey Zirger 404 639-7118 [email protected]

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
		(a) It is necessary for the proper performance of agency functions;
		(b) It avoids unnecessary duplication;
		(c) It reduces burden on small entities;
		(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;
		(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;
		(f) It indicates the retention periods for recordkeeping requirements;
		(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:
			(i) Why the information is being collected;
			(ii) Use of information;
			(iii) Burden estimate;
			(iv) Nature of response (voluntary, required for a benefit, or mandatory);
			(v) Nature and extent of confidentiality; and
			(vi) Need to display currently valid OMB control number;
		(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.
		(i) It uses effective and efficient statistical survey methodology (if applicable); and
		(j) It makes appropriate use of information technology.
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
Certification Date: 06/03/2025

---